Testing for thrombophilia: an evidence-based approach

L. Merriman, Michael Greaves

Research output: Contribution to journalLiterature review

35 Citations (Scopus)

Abstract

Thrombophilia is a disorder of haemostasis in which there is a tendency for the occurrence of thrombosis. This tendency can be inherited or acquired. This review outlines common acquired and inherited thrombophilic conditions and discusses indications for testing. It is concluded that testing for acquired thrombophilic conditions should be considered in all cases of venous thrombosis, whereas testing for inherited thrombophilic conditions is unlikely to be helpful. If testing for inherited thrombophilia is to be carried out, the benefits, pitfalls and unwanted consequences of such testing should be taken into account.

Original languageEnglish
Pages (from-to)699-704
Number of pages6
JournalPostgraduate Medical Journal
Volume82
DOIs
Publication statusPublished - 2006

Keywords

  • Factor V Leiden
  • recurrent venous thromboembolism
  • deep-vein thrombosis
  • replacement therapy
  • prospective cohort
  • family members
  • risk factors
  • heterozgous carriers
  • oral contraceptives
  • protein C

Cite this

Testing for thrombophilia : an evidence-based approach. / Merriman, L.; Greaves, Michael.

In: Postgraduate Medical Journal, Vol. 82, 2006, p. 699-704.

Research output: Contribution to journalLiterature review

Merriman, L. ; Greaves, Michael. / Testing for thrombophilia : an evidence-based approach. In: Postgraduate Medical Journal. 2006 ; Vol. 82. pp. 699-704.
@article{23fd8946332e475f8b8415aff5022fcf,
title = "Testing for thrombophilia: an evidence-based approach",
abstract = "Thrombophilia is a disorder of haemostasis in which there is a tendency for the occurrence of thrombosis. This tendency can be inherited or acquired. This review outlines common acquired and inherited thrombophilic conditions and discusses indications for testing. It is concluded that testing for acquired thrombophilic conditions should be considered in all cases of venous thrombosis, whereas testing for inherited thrombophilic conditions is unlikely to be helpful. If testing for inherited thrombophilia is to be carried out, the benefits, pitfalls and unwanted consequences of such testing should be taken into account.",
keywords = "Factor V Leiden, recurrent venous thromboembolism , deep-vein thrombosis, replacement therapy, prospective cohort, family members, risk factors, heterozgous carriers, oral contraceptives, protein C",
author = "L. Merriman and Michael Greaves",
year = "2006",
doi = "10.1136/pgmj.2006.048090",
language = "English",
volume = "82",
pages = "699--704",
journal = "Postgraduate Medical Journal",
issn = "0032-5473",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Testing for thrombophilia

T2 - an evidence-based approach

AU - Merriman, L.

AU - Greaves, Michael

PY - 2006

Y1 - 2006

N2 - Thrombophilia is a disorder of haemostasis in which there is a tendency for the occurrence of thrombosis. This tendency can be inherited or acquired. This review outlines common acquired and inherited thrombophilic conditions and discusses indications for testing. It is concluded that testing for acquired thrombophilic conditions should be considered in all cases of venous thrombosis, whereas testing for inherited thrombophilic conditions is unlikely to be helpful. If testing for inherited thrombophilia is to be carried out, the benefits, pitfalls and unwanted consequences of such testing should be taken into account.

AB - Thrombophilia is a disorder of haemostasis in which there is a tendency for the occurrence of thrombosis. This tendency can be inherited or acquired. This review outlines common acquired and inherited thrombophilic conditions and discusses indications for testing. It is concluded that testing for acquired thrombophilic conditions should be considered in all cases of venous thrombosis, whereas testing for inherited thrombophilic conditions is unlikely to be helpful. If testing for inherited thrombophilia is to be carried out, the benefits, pitfalls and unwanted consequences of such testing should be taken into account.

KW - Factor V Leiden

KW - recurrent venous thromboembolism

KW - deep-vein thrombosis

KW - replacement therapy

KW - prospective cohort

KW - family members

KW - risk factors

KW - heterozgous carriers

KW - oral contraceptives

KW - protein C

U2 - 10.1136/pgmj.2006.048090

DO - 10.1136/pgmj.2006.048090

M3 - Literature review

VL - 82

SP - 699

EP - 704

JO - Postgraduate Medical Journal

JF - Postgraduate Medical Journal

SN - 0032-5473

ER -